- Home
- DFLI vs TXMD Comparison
DFLI vs TXMD Comparison
Compare DFLI & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DFLI | TXMD |
|---|---|---|
| Founded | 2020 | 2008 |
| Country | United States | United States |
| Employees | 141 | N/A |
| Industry | Electronic Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.2M | 24.4M |
| IPO Year | N/A | 2012 |
Fundamental Metrics
Financial Performance| Metric | DFLI | TXMD |
|---|---|---|
| Price | $1.94 | $2.13 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.25 | N/A |
| AVG Volume (30 Days) | ★ 425.9K | 54.9K |
| Earning Date | 05-14-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 73.68 |
| EPS | N/A | ★ 0.01 |
| Revenue | N/A | ★ $1,761,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $51.17 | N/A |
| P/E Ratio | ★ N/A | $227.00 |
| Revenue Growth | N/A | ★ 35.25 |
| 52 Week Low | $0.15 | $0.98 |
| 52 Week High | $5.15 | $2.95 |
Technical Indicators
Market Signals| Indicator | DFLI | TXMD |
|---|---|---|
| Relative Strength Index (RSI) | 51.02 | 52.17 |
| Support Level | $1.89 | $2.10 |
| Resistance Level | $2.26 | $2.32 |
| Average True Range (ATR) | 0.16 | 0.15 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 50.45 | 50.00 |
Price Performance
Historical ComparisonAbout DFLI Dragonfly Energy Holdings Corp. (NV)
Dragonfly Energy Holdings Corp is engaged in the design, assembly, and sale of lithium-ion batteries, mainly lithium iron phosphate (LFP) batteries, for applications in recreational vehicles, marine, industrial, and other markets. The company operates through two segments: direct-to-consumer (DTC), which sells Battle Born branded batteries, and OEM, which supplies Dragonfly branded batteries to original equipment manufacturers.
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company that owns and manages intellectual property, including trademarks and product rights, which are licensed to third-party pharmaceutical companies. The company generates revenue mainly through royalties and milestone payments from licensed products, including IMVEXXY, BIJUVA, and ANNOVERA, and does not directly manufacture or market pharmaceutical products.